Viewing Study NCT00176293


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2026-01-06 @ 12:52 PM
Study NCT ID: NCT00176293
Status: TERMINATED
Last Update Posted: 2015-04-21
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer
Sponsor: University of Kentucky
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 04-GU-52-B
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: John Rinehart, M.D., Principal Investigator
Old Organization: University of Kentucky

Collaborators

Collaborators

Name Class View
None INDUSTRY View